CTOs on the Move

Acreage Holdings

www.acreageholdings.com

 
Headquartered in New York City, Acreage is a multi-state operator of cannabis ‎cultivation and retailing facilities in the U.S., including the company`s national retail store ‎brand, The Botanist. Acreage`s wide range of national and regionally available cannabis products include the award-winning Botanist brand, the highly recognizable Tweed brand, the Prime medical brand in Pennsylvania, the Innocent edibles brand in Illinois and others. Acreage also owns Universal Hemp, LLC, a hemp subsidiary dedicated to the distribution, marketing and sale of CBD products throughout the U.S. Since its founding in 2011, Acreage has focused on building and scaling operations to create a ...
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Funding

Acreage Holdings raised $119M on 07/23/2018
Acreage Holdings raised $30M on 02/10/2020
Acreage Holdings raised $15M on 06/17/2020
Acreage Holdings raised $28M on 11/03/2020
Acreage Holdings raised $33M on 09/29/2020

Similar Companies

Synergy Health Partners

Synergy Health Partners is the car accident doctor you can trust. We offer chiropractic treatment, physical therapy, and massages.

Cherry Tree Dental

Our dedication to small, one- or two-dentist practices sets us apart from large, impersonal dental management companies. You’ll never see Cherry Tree Dental’s name on the building or ten doctors at one office. We value established, family practices, hi...

TruHearing

TruHearing works with health plans to offer low out of pocket costs on hearing aids. Ask a Hearing Consultant if your insurance qualifies: 844-319-3988

Tricol Biomedical

Tricol Biomedical is dedicated to significantly advancing the standard of care in hemostatic and wound care management with a broad array of products.

Tracon Pharmaceuticals

Tracon Pharmaceuticals, is a biopharmaceutical company that licenses, develops, and commercializes targeted therapies for cancer and age-related macular degeneration. The current pipeline takes advantage of established platform technologies to block novel pathways implicated in cancer growth and angiogenesis.